What Happens During The Procedure? Blood Pressure Procedure (RDN)

RDN

Once you and your doctor decide that your treatment path forward includes RDN, you will have discussed the benefits and risks of the procedure as well as what to expect.

On the day of or day before your scheduled procedure, your doctor will take your blood pressure and confirm eligibility and address any final questions that you may have regarding the procedure.

The procedure typically takes about an hour to perform.1,2

AN EFFECTIVE HYPERTENSION TREATMENT

Here is a step-by-step guide of what generally happens during the Blood Pressure Procedure: 

  • You will receive an intravenous line (IV) to administer fluids and medications, and your blood pressure and heart rhythm will be monitored.
  • Your doctor will insert a small tube into an artery near your hip. This tube will be guided to the arteries that supply blood to your kidneys. The overactive nerves that may be causing high blood pressure are located outside the walls of these arteries.
  • Special dye (contrast) will be injected through the tube into your bloodstream to allow your doctor to see your arteries on an x-ray monitor.
  • If your arteries are confirmed to be suitable for the procedure, your doctor 
will begin treatment by delivering energy to the overactive nerves.
  • After the RDN procedure is performed, the tube is removed.
  • The RDN procedure requires no implant to the kidneys or the arteries near 
the kidney.

DOWNLOAD THE BROCHURE

pdf The Blood Pressure Procedure (.pdf)

This guide will give you a high-level overview of how to better manage your high blood pressure.

1.8MB

1

Böhm et al. Safety and efficacy measurements in the Global SYMPLICITY Registry, EuroPCR 2017

2

Individual procedure times may vary.


© 2017 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. ™* Third-party brands are trademarks of their respective owners. For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan, France, Denmark, Spain.